Brief: Blue Vision Makes Conditional Purchase Offer For Reponex Pharmaceuticals
April 5 (Reuters) - Blue Vision A/S BLVISa.CO :
* MAKES CONDITIONAL PRURCHASE OFFER FOR REPONEX
PHARMACEUTICALS
A/S
* OFFER PRICE IS DKK 180.55 PER SHARE
* OFFER IS VALID FROM APRIL 5, 2022 TILL MAY 3, 2022
Source text for Eikon: ID:nGNE3Hdgmg
Further company coverage: BLVISa.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations